CYP3A4 Inhibition Assay Protocol
Corresponding Organization :
Other organizations : Sanofi (France), Evotec (United States), Texas A&M University, University of Illinois at Chicago, Institut de génétique et de biologie moléculaire et cellulaire, TB Alliance, Johns Hopkins Medicine, Johns Hopkins University
Variable analysis
- Increasing concentrations of GM, MGM or CGM (concentration range: 1 - 30 μM)
- Formation of 1'-hydroxymidazolam and 6β-hydroxytestosterone metabolites
- 0.1 mg/mL human liver microsomes (pooled batch from 150 donors)
- Incubation medium: 0.05 M phosphate buffer (pH 7.4) containing an NADPH regenerating system (including 1.3 mM NADP, 3.3 mM glucose 6-phosphate, 3.3 mM MgCl2, and 1.0 U/mL glucose 6-phosphate dehydrogenase)
- Probe CYP3A4 substrates: Midazolam at 3 μM and testosterone at 50 μM
- Incubation time: 10 min for midazolam, 30 min for testosterone
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!